Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia
FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia
FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia
Submitted by
admin
on January 30, 2013 - 10:36am
Source:
Forbes
News Tags:
mipomersen
Kynamro
Isis Pharmaceuticals
Homozygous Familial Hypercholesterolemia
Genzyme
FDA
Headline:
FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia
Do Not Allow Advertisers to Use My Personal information
